Will resume COVID-19 vaccine trials after DCGI nod: Serum Institute

Pharma giant AstraZeneca on Saturday said that clinical trials for the AstraZeneca Oxford coronavirus vaccine, AZD1222, have resumed in the UK following confirmation by the Medicines Health Regulatory Authority (MHRA) that the trials were safe.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3iCW85n
via IFTTT